Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$31.9M Buy
748,415
+169,474
+29% +$7.21M 0.02% 695
2016
Q3
$27.5M Buy
578,941
+47,267
+9% +$2.36M 0.01% 723
2016
Q2
$26.8M Sell
531,674
-21,382
-4% -$1.08M 0.01% 715
2016
Q1
$26.7M Buy
553,056
+27,998
+5% +$1.08M 0.01% 725
2015
Q4
$20.6M Buy
525,058
+29,233
+6% +$1.17M 0.01% 770
2015
Q3
$18.8M Buy
495,825
+262,872
+113% +$11.1M 0.01% 777
2015
Q2
$9.26M Buy
232,953
+206,692
+787% +$6.44M 0.01% 988
2015
Q1
$703K Buy
26,261
+3,999
+18% +$113K ﹤0.01% 2048
2014
Q4
$654K Sell
22,262
-438
-2% -$10.8K ﹤0.01% 2123
2014
Q3
$457K Sell
22,700
-1,135
-5% -$21.9K ﹤0.01% 2203
2014
Q2
$399K Sell
23,835
-6,127
-20% -$86.8K ﹤0.01% 2285
2014
Q1
$446K Buy
29,962
+3,242
+12% +$49.9K ﹤0.01% 2276
2013
Q4
$391K Buy
26,720
+2,685
+11% +$43.2K ﹤0.01% 2282
2013
Q3
$413K Buy
24,035
+5,686
+31% +$84.3K ﹤0.01% 2299
2013
Q2
$213K Buy
+18,349
New +$210K ﹤0.01% 2265

Other funds holding AMED

BlackRock Group's AMED Position: Q4 2016 in Review

BlackRock Group increased its Amedisys (AMED) stake by 29% in Q4 2016, buying an estimated $7.21M and bringing the position to 748,415 shares worth $31.9M. The position accounts for 0.02% of the portfolio, ranked #695.

BlackRock Group first reported a position in AMED in Q2 2013 and has held it in 15 quarters since. 159 funds tracked by Wall St. Rank hold AMED as of Q4 2016.

  • BlackRock Group held 748,415 shares of Amedisys worth $31.9M as of Q4 2016.
  • BlackRock Group bought 169,474 Amedisys shares in Q4 2016, an estimated $7.21M.
  • Amedisys made up 0.02% of BlackRock Group's portfolio in Q4 2016, its #695 holding.
  • BlackRock Group first reported a position in Amedisys in Q2 2013 and has held it in 15 quarters since.
  • 159 funds tracked by Wall St. Rank held Amedisys as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.